We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 01, 2020

Hydroxychloroquine in Patients With Mild to Moderate Coronavirus Disease 2019

BMJ : British Medical Journal

 

Additional Info

BMJ : British Medical Journal
Hydroxychloroquine in Patients With Mainly Mild to Moderate Coronavirus Disease 2019: Open Label, Randomised Controlled Trial
BMJ 2020 May 14;369(xx)m1849, W Tang, Z Cao, M Han, Z Wang, J Chen, W Sun, Y Wu, W Xiao, S Liu, E Chen, W Chen, X Wang, J Yang, J Lin, Q Zhao, Y Yan, Z Xie, D Li, Y Yang, L Liu, J Qu, G Ning, G Shi, Q Xie

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading